Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-20

Clinical Trial Update: Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and tolerability of armodafinil in adults with excessive sleepiness due to shift work disorder; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NUVIGIL (armodafinil)

Snippet

Sponsor: Cephalon | Conditions: Excessive Sleepiness | Phase 4 | Status: COMPLETED | Results posted: 2012-06-20